Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05734313 · ClinicalTrials.gov registry record · NA
Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression
A NA study of Diabetes and Type 1 Diabetes, sponsored by Albert Einstein College of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 94
- Enrollment target
- 2
- Study locations
NCT05734313 is a NA study of Diabetes and Type 1 Diabetes that is actively recruiting participants, run by Albert Einstein College of Medicine. The registered enrollment target is 94 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05734313, a NA study of Diabetes and Type 1 Diabetes, is actively recruiting participants, sponsored by Albert Einstein College of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 94 participants
- Enrollment target
- 2
- Study locations
Study Summary
This project will evaluate a telemedicine-delivered, Unified Protocol for Cognitive-Behavioral Therapy (UP-CBT) enhanced with continuous glucose monitor (CGM) review to target anxiety and depressive symptoms and glycemic control in adults with type 1 diabetes.
Conditions Studied
Interventions
- DEVICE Continuous Glucose Monitoring (CGM)
- BEHAVIORAL Unified protocol for cognitive behavioral therapy (UP-CBT)
Study Locations (2)
Massachusetts
- Boston University - Boston
New York
- Albert Einstein College of Medicine - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2023-03-31 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05734313
The ClinicalTrials.gov registry entry for NCT05734313 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (97% lower). The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Continuous Glucose Monitoring (CGM) is the first listed.
NCT05734313 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, New York.
Frequently Asked Questions
What is clinical trial NCT05734313 about?
NCT05734313 is a clinical study titled "Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression". This project will evaluate a telemedicine-delivered, Unified Protocol for Cognitive-Behavioral Therapy (UP-CBT) enhanced with continuous glucose monitor (CGM) review to target anxiety and depressive symptoms and glycemic control in adults with type 1 diabetes.
What is the current status of trial NCT05734313?
This trial is currently recruiting. It is a NA study. The enrollment target is 94 participants. The study started on 2023-03-31. Estimated completion is 2027-12.
What conditions does trial NCT05734313 study?
This clinical trial studies the following conditions: Diabetes, Type 1 Diabetes.
What interventions are being tested in trial NCT05734313?
The interventions under investigation include: Continuous Glucose Monitoring (CGM) (DEVICE), Unified protocol for cognitive behavioral therapy (UP-CBT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05734313?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05734313 being conducted?
This trial has 2 study locations across Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
Bringing Advocacy Via Digital Guide to the Emergency Department (Project BADGE)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.